Nea Management Company, LLC Mirum Pharmaceuticals, Inc. Transaction History

Nea Management Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$23.51 - $30.09 $47 Million - $60.2 Million	-2,000,000 Reduced 47.78%	2,186,243 $56.6 Million
Q4 2022 Feb 10, 2023	SELL	$17.59 - $23.83 $27,405 - $37,127	-1,558 Reduced 0.04%	4,186,243 $81.6 Million
Q3 2019 Oct 11, 2019	BUY	$9.16 - $14.77 $38.4 Million - $61.9 Million	4,187,801 New	4,187,801 $42.1 Million

201

54.7M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.86B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.